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Knitting up the ravelled sleeve of care: sleep and psychosis
Sleep problems are pervasive in people with schizo-
phrenia. There is a strong documented link between 
insomnia and psychosis symptoms, and longitudinal 
studies1 suggest that insomnia predicts new episodes of 
paranoia. We cannot assume that standard interventions 
for insomnia will be successful in psychosis and no trial 
of such interventions in psychosis has been done. On 
this basis, Daniel Freeman and colleagues’ study2 in 
The Lancet Psychiatry is well founded. This pilot feasibility 
trial assesses the beneﬁ t of cognitive behavioural therapy 
(CBT) in the context of insomnia in individuals with 
a schizophrenia spectrum diagnosis and persistent 
delusions or hallucinations. Participants were successfully 
recruited, adhered to treatment, and were followed up 
to a high level. The CBT intervention was well received 
by participants, leading to reductions in the primary 
outcome measure of levels of insomnia 12 weeks after 
treatment (adjusted mean diﬀ erence 6·1, 95% CI 3·0–9·2, 
eﬀ ect size d=1·9). Despite reductions in insomnia in the 
large eﬀ ect size range, there was only a weak indication 
that the intervention would lead to improvements in 
psychosis symptoms, including paranoia. 
This trial comes at a time when conventional CBT for 
psychosis, although recommended by NICE, has come 
under scrutiny,3 and for good reason: the eﬀ ect sizes of 
this ﬁ rst wave of CBT for psychosis are small to moderate 
in terms of eﬀ ect on psychosis itself. This outcome 
was evident nearly 10 years ago; we argued that CBT 
should concentrate mainly on the aﬀ ective dimension of 
psychosis (which is after all where CBT cut its teeth) and 
on well theorised mechanisms.4 The aﬀ ective dimension 
in psychosis is increasingly understood, as is its link with 
psychosis onset and persistence.5 CBT for psychosis has 
become a very complex intervention and, because the 
population under study is heterogeneous, it risks losing 
impact because the eﬀ ect on individual mechanisms and 
outcomes is diluted.  
Freeman and colleagues’ study is an excellent example 
of the new wave of CBT interventions in psychosis 
focusing on the aﬀ ective dimension and theoretically 
driven treatment targets, and for which trials are 
parsimonious and focused on hypothesised mechanisms. 
The emphasis on feasibility, acceptability, and eﬀ ect sizes 
in the present study, rather than on p values, is apposite. 
Notable is the very high rate of completion of the CBT 
intervention (96%) and the high acceptability, similar to 
that achieved in equally focused interventions for post-
traumatic stress disorder and command hallucinations in 
psychosis.6,7 The Schizophrenia Commission emphasised 
the need for new interventions, particularly those 
with high acceptability, which current, predominantly 
drug-based, treatments tend not to have.8 This sleep 
intervention satisﬁ es this requirement. 
However, one of the downsides of focusing on single, 
but nevertheless important, symptoms is that they are 
rarely present alone. In this case, sleep diﬃ  culty usually 
accompanies depression and anxiety. The question 
is raised as to what extent insomnia is embedded in 
depression; indeed, many patients in the present study 
were receiving SSRIs and most were severely depressed. 
This issue is important from a theoretical perspective, 
because depression and emotional dysregulation have 
generally been implicated in the ontogeny of psychosis; 
moreover, depression and suicidal thinking are, over 
time, virtually ubiquitous in patients with psychosis.9 The 
deﬁ nitive trial should examine depression as a mediator 
of any eﬀ ect on paranoia.
Although the eﬀ ect of CBT on insomnia was in the 
large range, the eﬀ ect on hallucinations and delusions 
was small at best. Importantly, the eﬀ ect on quality 
of life and overall fatigue was in the medium range, 
underscoring the notion that CBT might be most 
eﬀ ective when focusing on distress and quality of life. 
Many individuals with persecutory thinking feel under 
threat and mitigate this in various diﬀ erent ways,10 
and threat monitoring and hypervigilance can lead to 
(or perhaps in some cases are the same as) insomnia. 
Although direct intervention in insomnia will still be a 
valid therapeutic approach, for some patients, it might 
increase the perceived threat. In this regard, there might 
be important subgroups in the case of any eﬀ ect of the 
intervention on psychosis, and the possibility of distinct 
responder and non-responder subgroups could be 
examined in the next trial.
Finally, the large variation in eﬀ ect sizes by the method 
and dimension of sleep assessed in the present study 
was intriguing, with the Insomnia Severity Index having 
the largest eﬀ ect size and actigraphy (total sleep time) 
the weakest. What was the cause of this variation and 
what do the secondary sleep outcomes measure that the 
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primary one does not? Consideration of these questions 
will no doubt be useful in planning of the next trial.
In conclusion, Freeman and colleagues’ new-wave, 
high-quality, feasibility trial fully deserves a deﬁ nitive 
randomised controlled trial and, like all good science, 
raises as many questions as it answers.
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Improved identiﬁ cation of people at risk of psychosis: is it 
value for money?
Development of a psychotic illness, including schizo-
phrenia, can be debilitating for the individual, with life 
expectancy reduced by up to 15 years,1 mainly due to an 
increased occurrence of cardiovascular disease.2 In the 
past 5 years, clinician preference has moved towards 
early detection and intervention by assessment of 
the risks for developing psychoses, with increasing 
evidence about the eﬀ ectiveness of early interventions 
for psychosis.3 Primary care can play an important part 
in the early identiﬁ cation of individuals at risk, because 
people with a serious mental illness have an estimated 
average 13–14 consultations with their general 
practitioner every year.4 However, evidence is scarce 
with respect to the assessment of factors contributing 
to the eﬀ ectiveness of improved detection of individuals 
at high risk of developing psychosis in primary care. 
Additionally, in an era of restricted health-care 
budgets, the assessment of cost-eﬀ ectiveness for this 
type of intervention is important. Cost-eﬀ ectiveness 
assessments attempt to quantify the trade-oﬀ  between 
improved outcomes for the individual and increased 
costs to the health-care system; in other words, does the 
intervention represent value for money? 
In The Lancet Psychiatry, Jesus Perez and colleagues5 
report both the clinical eﬀ ectiveness and cost-eﬀ ective-
ness of a theory-based early intervention to improve 
liaison between primary and secondary care in UK 
primary care practices. High-intensity and low-intensity 
liaisons were assessed (26 practices in high-intensity 
intervention and 28 in low-intensity intervention), as 
was practice as usual (50 practices). The authors5 report 
that practices randomly assigned to the high-intensity 
intervention referred more individuals for ﬁ rst-episode 
psychosis to the early intervention services than did 
the other two practice groups (high intensity vs low 
intensity; incidence rate ratio [IRR] 1·9, 95% CI 1·05–3·4, 
p=0·04), although for individuals at high risk of 
psychosis the increase was not  signiﬁ cant. As a result, 
high-intensity practices referred both more true-
positive and false-positive cases of psychosis conﬁ rmed 
after assessment.
The increased referral of individuals at high risk of 
psychosis suggests that the high-intensity intervention 
is clinically eﬀ ective, but what about its cost-
eﬀ ectiveness? Implementation of the high-intensity 
liaison intervention was estimated to cost £1459 per 
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